Rabaca, Mary Jane H.
HRN: 19-45-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2022
AMPICILLIN 1GM (VIAL)
12/11/2022
12/18/2022
IV
2gm
Q6H
PROM
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes